What's new

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised

Feb 13, 2025 - 16:45
 0
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Nimenrix, meningococca...

Next Article

EMEA-003469-PIP01-23

Related Posts

Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Agenda of the CAT meeting 19-21 February 2025

Feb 18, 2025  0

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0